Issue of Equity

 
TIDMMEDG 
 
Medgenics, Inc. 
                         ('Medgenics' or the 'Company') 
 
                                 Issue of Equity 
 
7 October 2009 
 
The  Company announces that on 6 October 2009 it completed a private placing  to 
raise  GBP265,200  and a Board resolution was passed to issue and allot  4,420,000 
common  shares of US  $0.0001 par value each ("Common Shares") conditional  upon 
admission to trading on AIM.  The new Common Shares were issued at a price of  6 
pence  per  Common  Share.  Application has now been made to  the  London  Stock 
Exchange  for  the New Common Shares to be admitted to trading on AIM.  Dealings 
are expected to commence at 8.00 a.m. on 12 October 2009. 
 
Following the admission to trading of the new Common Shares, the Company's total 
issued share capital will be 122,174,028* Common Shares of US $0.0001 each,  the 
percentage of AIM Securities not in public hands will be 29.4%*. 
 
Note 
*  Excluding any Common Shares issued pursuant to the block admission between  4 
June 2009 and the date of this announcement. 
 
For further information, contact: 
 
Medgenics, Inc.                                                [phone] 
Dr. Andrew L. Pearlman 
 
Grayling (Public Relations)                                    [phone] 
Dr. Mark Swallow 
Jonathan Shillington (Global Consulting Group) 
 
Blomfield Corporate Finance (Nomad)                            [phone] 
James Pinner 
Alan MacKenzie 
 
SVS Securities plc (Broker)                                    [phone] 
Peter Manfield or 
Ian Callaway